Image Source: PixabayTM Editors’ note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.Haw Par Corp Ltd (HAWPF) is a major drug manufacturing company that operates multiple brands. The company’s primary strategy is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions.Its three operating segments include:  (1) Healthcare, (2) Investments, and (3) Others segment. The company generates maximum revenue from Healthcare. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands.Geographically, it generates a majority of its revenue from South East Asian countries.Haw Par Corporation Limited was incorporated in 1969 and is based in Singapore.Three key data points gauge Haw Par Corp or any dividend-paying firm.The key three are:(1) Price(2) Dividends(3) ReturnsThose three basic keys also best tell whether any company has made, is making, and will make money.HAWPF PriceOver the past year, Haw Par’s share price increased about 4.3% from $7.00 to $7.30 as of Wednesday’s market close.If HAWPF shares trade in the range of $6.50 to $8.00 this next year, its recent $7.30 share price might rise to $7.55 by next year. Of course, HAWPF price could also drop about the same $0.25 estimated amount or more.My $0.25 upside estimate is in line with the Haw Par average annual price gains over the past 8 years.HAWPF DividendHaw Par has paid semi-annual variable dividends since May 2009 except for the year 2017.Haw Par’s most recent SA dividend of $0.15 was declared on February 26th for shareholders of record on May 3rd and the dividend was paid on May 21st.A forward-looking $0.30 annual dividend yields 4.05% at Wednesday’s $7.40 share price.HAWPF ReturnsTo put it all together, add the Haw Par projected annual dividend of $0.30 to the estimated price upside of $0.25 to get a $0.55 estimated gross gain for the coming year.At Tuesday’s $7.40 share price, a little under $1000 would buy 135 shares.A $10 broker fee (if charged), paid half at purchase and half at sale, would cost us about $0.075 per share.Subtracting that unlikely $0.075 brokerage cost from the $0.55 estimated gross gain reveals a net gain of $0.475 X 135 shares = $64.13 for about a 6.4% estimated net gain on the year.Furthermore, the $40.50 annual dividend income from $1K invested is nearly 5.5 times more than the single share price. By these numbers, HAWPF is an ideal dividend dog.You might choose to pounce on Haw Par Corp Ltd. It is a 55-year-old dividend-paying Singapore-based healthcare and investment firm that has a 14 to 15-year track record paying semi-annual variable dividends.The exact track of Haw Par Corp’s future price and dividend will entirely be determined by market action.Remember the true value of any stock is best realized through personal ownership of shares.More By This Author:Stock Analysis: Fresenius Medical Care
Current Analysis: Elekta AB [EKTAF]
Stock Analysis: Svenska Handelsbanken